Search for: "AmerisourceBergen Corporation" Results 61 - 77 of 77
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
19 Dec 2012, 9:47 pm by Ben Vernia
An additional case was resolved by a related settlement: In a separate civil settlement, International Nephrology Network (INN), renamed Integrated Nephrology Network, a subsidiary of AmerisourceBergen Corporation, has also agreed to pay $15 million to resolve civil liability arising from its role in the marketing of Aranesp. [read post]
23 Nov 2009, 7:20 pm
 He brought proceedings for personal injuries against the manufacturer (Amgen), the wholesale distributor (Amerisourcebergen), and the retailers (CVS Corporation and ProCare Pharmacy). [read post]
23 Mar 2020, 4:21 pm by Kandace Watson
(CCH) P94,334 (“[Directors] may find it prudent (and are authorized) to make decisions that are expected to promote corporate (and shareholder) long run interests, even if short run share value can be expected to be negatively affected, and thus directors in pursuit of long run corporate (and shareholder) value may be sensitive to the claims of other ‘corporate constituencies. [read post]
18 Nov 2019, 4:24 am by Whittel & Melton, LLC
In recent lawsuits, the defendants have included McKesson Corporation, Cardinal Health, AmerisourceBergen, Purdue Pharma, Janssen Pharmaceuticals (a subsidiary of Johnson & Johnson), Endo International, Teva Pharmaceutical, Allergan (formerly Actavis), Watson Pharmaceuticals, Covidien, Johnson & Johnson, CVS, Walgreens, and Rite Aid. [read post]
31 Jan 2022, 9:41 am by David W.S. Lieberman
Cardinal Health will also enter into a compliance program, called a Corporate Integrity Agreement with the Department of Health and Human Services Office of Inspector General. [read post]
29 Jan 2021, 6:01 am
Posted by the Harvard Law School Forum on Corporate Governance & Financial Regulation, on Friday, January 29, 2021 Editor's Note: This roundup contains a collection of the posts published on the Forum during the week of January 21-28, 2021. [read post]
16 Dec 2021, 12:15 pm by Simmons Hanly Conroy
After six long months, the once-sprawling case has seen a number of key results in favor of plaintiffs, including: Former opioid manufacturer Allergan agreed to a $200 million settlement with New York State and Suffolk and Nassau Counties Endo Pharmaceuticals and its subsidiaries agreed to a settlement with New York State, and Suffolk and Nassau Counties, totaling $50 million Johnson & Johnson settled with the state of New York for $230 million, and as part of their agreement, the company agreed… [read post]
21 Jan 2022, 2:17 pm by luiza
State and local entities continued their enforcement efforts against opioid manufacturers and distributors, with mega-settlements entered into between thousands of state and local entities and drug manufacturers Johnson & Johnson and Indivior, and drug distributors McKesson Corporation, Cardinal Health Inc., and AmerisourceBergen Drug Corporation. [read post]
21 Jan 2022, 2:17 pm by luiza
State and local entities continued their enforcement efforts against opioid manufacturers and distributors, with mega-settlements entered into between thousands of state and local entities and drug manufacturers Johnson & Johnson and Indivior, and drug distributors McKesson Corporation, Cardinal Health Inc., and AmerisourceBergen Drug Corporation. [read post]
7 Sep 2020, 2:06 pm by Kevin LaCroix
Among many other things, investors and activists are raising concerns about the lack of racial diversity on corporate boards. [read post]
23 Jan 2023, 10:40 am by David W.S. Lieberman
Mallinckrodt also entered a 5-year Corporate Integrity Agreement (CIA) with Department of Health and Human Services. [read post]
1 May 2007, 1:06 am
Abramson's recent decision in AmerisourceBergen Drug Corp. v. [read post]
1 Jan 2019, 5:10 pm by Ben Vernia
   https://www.justice.gov/opa/pr/amerisourcebergen-corporation-agrees-pay-625-million-resolve-allegations-it-illegally. [read post]
4 Jan 2021, 1:26 pm by Kevin LaCroix
The directors’ and officers’ liability environment is always changing, but 2020 was a particularly eventful year, with important consequences for the D&O insurance marketplace. [read post]
25 May 2022, 9:01 pm by Richard Zelichov and Trevor T. Garmey
  The SEC’s Division of Corporate Finance first issued Guidance Topic No. 9 on March 25, 2020. [read post]
19 Apr 2022, 5:05 am by David W.S. Lieberman
The Anti-Kickback Statute prohibits offering or accepting kickbacks intended to generate health care business. [read post]